KYNB: Singer Andrew E. discloses securities transactions
By AlphaYouPublished Form 4
Singer Andrew E.
Reporting filer
Singer Andrew E. reported Grant or award in KYNTRA BIO, INC.: 14000 units of Stock Option (Right to Buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Singer Andrew E. | 2026-10-01 | A | Grant or award | 14000 | 0 | 14,000 | 5 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Singer Andrew E.
- Date
- 2026-10-01
- Code
- A
- Action
- Grant or award
- Quantity
- 14000
- Price
- 0
- Following holdings
- 14,000
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 6.5
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 14000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-09-30
- underlying Security Title: Common Stock
- underlying Security Shares: 14000
- shares Owned Following Transaction: 14000
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Singer Andrew E.: Director.
- F1: The shares subject to the option shall vest in twelve equal quarterly installments measured from the date of grant.
Original sources
Prepared automatically from public filing data. Report a correction.